These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1098 related items for PubMed ID: 27889187

  • 1. Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.
    Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.
    Biol Psychiatry; 2017 Nov 01; 82(9):651-659. PubMed ID: 27889187
    [Abstract] [Full Text] [Related]

  • 2. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?
    Cesta CE, Öberg AS, Ibrahimson A, Yusuf I, Larsson H, Almqvist C, D'Onofrio BM, Bulik CM, Fernández de la Cruz L, Mataix-Cols D, Landén M, Rosenqvist MA.
    Psychol Med; 2020 Mar 01; 50(4):616-624. PubMed ID: 30857571
    [Abstract] [Full Text] [Related]

  • 3. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study.
    Chen X, Kong L, Piltonen TT, Gissler M, Lavebratt C.
    Hum Reprod; 2020 Oct 01; 35(10):2336-2347. PubMed ID: 32866965
    [Abstract] [Full Text] [Related]

  • 4. Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: a population-based nationwide study in Sweden.
    Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.
    Mol Psychiatry; 2016 Oct 01; 21(10):1441-8. PubMed ID: 26643539
    [Abstract] [Full Text] [Related]

  • 5. Maternal polycystic ovary syndrome and the potential risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in the offspring: a systematic review and meta-analysis.
    Abu-Zaid A, Bhagavathula AS, Rahmani J, Alyoubi RA, Alomar O, Baradwan S, Alkhamis WH, Khalifa M, Alshahrani MS, Khadawardi K, Salem H, A Al-Badawi I.
    Eur J Contracept Reprod Health Care; 2022 Jun 01; 27(3):253-260. PubMed ID: 35191798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of Neurodevelopmental Disorders in Offspring of Mothers With Eating Disorders in Sweden.
    Mantel Ä, Örtqvist AK, Hirschberg AL, Stephansson O.
    JAMA Netw Open; 2022 Jan 04; 5(1):e2143947. PubMed ID: 35040968
    [Abstract] [Full Text] [Related]

  • 10. Maternal polycystic ovary syndrome and attention deficit hyperactivity disorder in offspring at 3 years of age: Odense Child Cohort.
    Dalgaard CM, Andersen MS, Jensen RC, Larsen PV, Find LG, Boye H, Jensen TK, Bilenberg N, Glintborg D.
    Acta Obstet Gynecol Scand; 2021 Nov 04; 100(11):2053-2065. PubMed ID: 34490610
    [Abstract] [Full Text] [Related]

  • 11. Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes.
    Berni TR, Morgan CL, Berni ER, Rees DA.
    J Clin Endocrinol Metab; 2018 Jun 01; 103(6):2116-2125. PubMed ID: 29648599
    [Abstract] [Full Text] [Related]

  • 12. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM.
    JAMA; 2017 Apr 18; 317(15):1553-1562. PubMed ID: 28418479
    [Abstract] [Full Text] [Related]

  • 13. Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome.
    Hergüner S, Harmancı H, Toy H.
    Int J Psychiatry Med; 2015 Apr 18; 50(3):317-25. PubMed ID: 26449924
    [Abstract] [Full Text] [Related]

  • 14. Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium.
    Kurth L, O'Shea TM, Burd I, Dunlop AL, Croen L, Wilkening G, Hsu TJ, Ehrhardt S, Palanisamy A, McGrath M, Churchill ML, Weinberger D, Grados M, Dabelea D.
    J Neurodev Disord; 2024 May 26; 16(1):26. PubMed ID: 38796448
    [Abstract] [Full Text] [Related]

  • 15. Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases.
    Instanes JT, Halmøy A, Engeland A, Haavik J, Furu K, Klungsøyr K.
    Biol Psychiatry; 2017 Mar 01; 81(5):452-459. PubMed ID: 26809250
    [Abstract] [Full Text] [Related]

  • 16. Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders.
    Wiegersma AM, Dalman C, Lee BK, Karlsson H, Gardner RM.
    JAMA Psychiatry; 2019 Dec 01; 76(12):1294-1304. PubMed ID: 31532497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two Nordic countries.
    Wang H, László KD, Gissler M, Li F, Zhang J, Yu Y, Li J.
    Eur J Epidemiol; 2021 May 01; 36(5):519-530. PubMed ID: 33948753
    [Abstract] [Full Text] [Related]

  • 19. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.
    Andersen SL, Laurberg P, Wu CS, Olsen J.
    BJOG; 2014 Oct 01; 121(11):1365-74. PubMed ID: 24605987
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations.
    Morales DR, Slattery J, Evans S, Kurz X.
    BMC Med; 2018 Jan 15; 16(1):6. PubMed ID: 29332605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.